Norris, Tom, Razieh, Cameron, Zaccardi, Francesco, Yates, Thomas, Islam, Nazrul, Gillies, Clare L, Chudasama, Yogini V, Rowlands, Alex V, Davies, Melanie J, McCann, Gerry P et al (show 8 more authors)
(2022)
Impact of cardiometabolic multimorbidity and ethnicity on cardiovascular/renal complications in patients with COVID-19.
HEART, 108 (15).
pp. 1200-1208.
ISSN 1355-6037, 1468-201X
Abstract
<h4>Objective</h4>Using a large national database of people hospitalised with COVID-19, we investigated the contribution of cardio-metabolic conditions, multi-morbidity and ethnicity on the risk of in-hospital cardiovascular complications and death.<h4>Methods</h4>A multicentre, prospective cohort study in 302 UK healthcare facilities of adults hospitalised with COVID-19 between 6 February 2020 and 16 March 2021. Logistic models were used to explore associations between baseline patient ethnicity, cardiometabolic conditions and multimorbidity (0, 1, 2, >2 conditions), and in-hospital cardiovascular complications (heart failure, arrhythmia, cardiac ischaemia, cardiac arrest, coagulation complications, stroke), renal injury and death.<h4>Results</h4>Of 65 624 patients hospitalised with COVID-19, 44 598 (68.0%) reported at least one cardiometabolic condition on admission. Cardiovascular/renal complications or death occurred in 24 609 (38.0%) patients. Baseline cardiometabolic conditions were independently associated with increased odds of in-hospital complications and this risk increased in the presence of cardiometabolic multimorbidity. For example, compared with having no cardiometabolic conditions, 1, 2 or ≥3 conditions was associated with 1.46 (95% CI 1.39 to 1.54), 2.04 (95% CI 1.93 to 2.15) and 3.10 (95% CI 2.92 to 3.29) times higher odds of any cardiovascular/renal complication, respectively. A similar pattern was observed for all-cause death. Compared with the white group, the South Asian (OR 1.19, 95% CI 1.10 to 1.29) and black (OR 1.53 to 95% CI 1.37 to 1.72) ethnic groups had higher risk of any cardiovascular/renal complication.<h4>Conclusions</h4>In hospitalised patients with COVID-19, cardiovascular complications or death impacts just under half of all patients, with the highest risk in those of South Asian or Black ethnicity and in patients with cardiometabolic multimorbidity.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | COVID-19, epidemiology, risk factors |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Infection, Veterinary and Ecological Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 10 Jan 2022 14:31 |
| Last Modified: | 06 Dec 2024 20:49 |
| DOI: | 10.1136/heartjnl-2021-320047 |
| Open Access URL: | http://dx.doi.org/10.1136/heartjnl-2021-320047 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3146129 |
Altmetric
Altmetric
